Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04058717 · ClinicalTrials.gov registry record · NA

Low Nicotine Cigarettes Plus Electronic Cigarettes

A NA study, sponsored by Milton S. Hershey Medical Center.

Completed
Registry status
NA
Development phase
88
Enrollment target

NCT04058717: Completed NA study, sponsored by Milton S. Hershey Medical Center.

NCT04058717 is a NA study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 88 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04058717, a NA study, has completed, sponsored by Milton S. Hershey Medical Center.

COMPLETED
Registry status
NA
Development phase
88 participants
Enrollment target

Study Summary

This study aims to determine the health effects of very low nicotine content in cigarettes, in conjunction with the availability of nicotine-containing electronic cigarettes (e-cigs) among smokers with mental health conditions (SMHC).

Primary Outcome

Measure of tobacco-specific nitrosamine

Interventions

  • OTHER Normal Nicotine Content research cigarettes
  • OTHER High Nicotine e-cigarette
  • OTHER Very Low Nicotine Content research cigarettes
  • OTHER Zero Nicotine e-cigarette

Trial Details

FieldValue
Enrollment Target 88 participants
Start Date 2021-06-01
Est. Completion 2024-08-12
Phase NA
Milton S. Hershey Medical Center

396 total trials

What the finished NCT04058717 record still lists

NCT04058717 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 4 interventions - of which Normal Nicotine Content research cigarettes is the first listed.

NCT04058717 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04058717 about?

NCT04058717 is a clinical study titled "Low Nicotine Cigarettes Plus Electronic Cigarettes". This study aims to determine the health effects of very low nicotine content in cigarettes, in conjunction with the availability of nicotine-containing electronic cigarettes (e-cigs) among smokers with mental health conditions (SMHC).

What is the current status of trial NCT04058717?

This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2021-06-01. Estimated completion is 2024-08-12.

What interventions are being tested in trial NCT04058717?

The interventions under investigation include: Normal Nicotine Content research cigarettes (OTHER), High Nicotine e-cigarette (OTHER), Very Low Nicotine Content research cigarettes (OTHER), Zero Nicotine e-cigarette (OTHER).

Who is sponsoring clinical trial NCT04058717?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04058717's enrollment target sits among peer trials

88 972nd of 2000 higher than 1,027 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03843463 · 88 participants · Phase 2

    Escitalopram and Language Intervention for Subacute Aphasia

  • NCT04066348 · 88 participants · Phase 2

    TNF-α Treatment of Blast-Induced Tinnitus

  • NCT04331704 · 88 participants · Phase 4

    ANCHORS Alcohol & Sexual Health Study: UH3 Project

  • NCT04536103 · 88 participants

    Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04058717, the US trial registry maintained by the National Library of Medicine. NCT04058717 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.